Menu

Filtros : "FÁRMACOS" "FCF-FBF" Removido: "Sociedade Brasileira de Física - SBF" Limpar

Filtros

Refine with date range

1 - 20 (342 records)

  • Artigo de periodico

    Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions (2023)

    Yukuyama, Megumi Nishitani ; Zuo, Jieyu; Park, Chulhun; Yousef, Malaz ; Henostroza, Mirla Anali Bazan; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: FÁRMACOS, ANTI-HELMÍNTICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, v. 632, p. 1-9 art. 122554, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122554. Acesso em: 01 jun. 2024.

    • APA

      Yukuyama, M. N., Zuo, J., Park, C., Yousef, M., Henostroza, M. A. B., Araujo, G. L. B. de, et al. (2023). Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, 632, 1-9 art. 122554. doi:10.1016/j.ijpharm.2022.122554

    • NLM

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554

    • Vancouver

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554

  • Artigo de periodico

    Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments (2023)

    Lirio, Adriana Cogo Malgueiro ; Diaz, Victor A. Febo; Chellappan, Dinesh Kumar ; Dua, Kamal ; Lourenço, Felipe Rebello ; Pinto, Terezinha de Jesus Andreoli

    Source: Journal of Pharmaceutical Innovation. Unidade: FCF

    Subjects: FÁRMACOS, MONITORAMENTO AMBIENTAL, CONTROLE DE PROCESSOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIRIO, Adriana Cogo Malgueiro et al. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, v. 18, p. 1362-1370, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12247-023-09719-4. Acesso em: 01 jun. 2024.

    • APA

      Lirio, A. C. M., Diaz, V. A. F., Chellappan, D. K., Dua, K., Lourenço, F. R., & Pinto, T. de J. A. (2023). Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, 18, 1362-1370. doi:10.1007/s12247-023-09719-4

    • NLM

      Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s12247-023-09719-4

    • Vancouver

      Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s12247-023-09719-4

  • Monografia/livro

    Fitoquímicos em alimentos, fármacos e medicamentos (2023)

    Fiamoncini, Jarlei ; Demarque, Daniel Pecoraro ; Crnkovic, Camila Manoel

    Unidade: FCF

    Subjects: FITOQUÍMICA, ALIMENTOS, FÁRMACOS, MEDICAMENTO

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FIAMONCINI, Jarlei e DEMARQUE, Daniel Pecoraro e CRNKOVIC, Camila Manoel. Fitoquímicos em alimentos, fármacos e medicamentos. . Santana de Parnaíba: Manole. . Acesso em: 01 jun. 2024. , 2023

    • APA

      Fiamoncini, J., Demarque, D. P., & Crnkovic, C. M. (2023). Fitoquímicos em alimentos, fármacos e medicamentos. Santana de Parnaíba: Manole.

    • NLM

      Fiamoncini J, Demarque DP, Crnkovic CM. Fitoquímicos em alimentos, fármacos e medicamentos. 2023 ;[citado 2024 jun. 01 ]

    • Vancouver

      Fiamoncini J, Demarque DP, Crnkovic CM. Fitoquímicos em alimentos, fármacos e medicamentos. 2023 ;[citado 2024 jun. 01 ]

  • Artigo de periodico

    Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats (2023)

    Souza, Aline de ; Almeida, Maria Karilly Lima de; Barbosa, João Antonio; Yukuyama, Megumi Nishitani ; Correia, Cristiano de Jesus; Faloppa, Ana Cristina Breithaupt ; Bou-Chacra, Nadia Araci ; Calixto, Leandro Augusto

    Source: Chemistry Africa. Unidades: FM, FCF

    Subjects: TRYPANOSOMA CRUZI, FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOUZA, Aline de et al. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, v. 6, p. 837-843, 2023Tradução . . Disponível em: https://doi.org/10.1007/s42250-022-00547-6. Acesso em: 01 jun. 2024.

    • APA

      Souza, A. de, Almeida, M. K. L. de, Barbosa, J. A., Yukuyama, M. N., Correia, C. de J., Faloppa, A. C. B., et al. (2023). Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, 6, 837-843. doi:10.1007/s42250-022-00547-6

    • NLM

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s42250-022-00547-6

    • Vancouver

      Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s42250-022-00547-6

  • Artigo de periodico

    Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines (2023)

    Caffaro, Arthur Massabki; Lourenço, Felipe Rebello

    Source: Chemometrics and Intelligent Laboratory Systems. Unidade: FCF

    Assunto: FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CAFFARO, Arthur Massabki e LOURENÇO, Felipe Rebello. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, v. 241, p. 1-9 art. 104935, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.chemolab.2023.104935. Acesso em: 01 jun. 2024.

    • APA

      Caffaro, A. M., & Lourenço, F. R. (2023). Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, 241, 1-9 art. 104935. doi:10.1016/j.chemolab.2023.104935

    • NLM

      Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935

    • Vancouver

      Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935

  • Artigo de periodico

    Absorption matters: a closer look at popular oral bioavailability rules for drug approvals (2023)

    Trossini, Gustavo Henrique Goulart ; Soares, Artur Caminero Gomes; Sousa, Gustavo Henrique Marques; Calil, Raisa Ludmila

    Source: Molecular informatics. Unidade: FCF

    Subjects: FÁRMACOS, ABSORÇÃO, BIODISPONIBILIDADE

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TROSSINI, Gustavo Henrique Goulart et al. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals. Molecular informatics, v. 42, n. 11, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1002/minf.202300115. Acesso em: 01 jun. 2024.

    • APA

      Trossini, G. H. G., Soares, A. C. G., Sousa, G. H. M., & Calil, R. L. (2023). Absorption matters: a closer look at popular oral bioavailability rules for drug approvals. Molecular informatics, 42( 11), 1-12. doi:10.1002/minf.202300115

    • NLM

      Trossini GHG, Soares ACG, Sousa GHM, Calil RL. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals [Internet]. Molecular informatics. 2023 ; 42( 11): 1-12.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/minf.202300115

    • Vancouver

      Trossini GHG, Soares ACG, Sousa GHM, Calil RL. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals [Internet]. Molecular informatics. 2023 ; 42( 11): 1-12.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1002/minf.202300115

  • Artigo de periodico

    Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years (2023)

    Vassiliades, Sandra Valeria ; Navarausckas, Vitor Bastos; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto

    Source: Biointerface Research in Applied Chemistry. Unidades: ICB, FCF

    Subjects: TUBERCULOSE, FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS, MICROBIOLOGIA, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VASSILIADES, Sandra Valeria et al. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, v. 13, n. 1 p. 1-20 art. 79, 2023Tradução . . Disponível em: https://doi.org/10.33263/BRIAC131.079. Acesso em: 01 jun. 2024.

    • APA

      Vassiliades, S. V., Navarausckas, V. B., Dias, M. V. B., & Parise Filho, R. (2023). Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, 13( 1 p. 1-20 art. 79). doi:10.33263/BRIAC131.079

    • NLM

      Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 jun. 01 ] Available from: https://doi.org/10.33263/BRIAC131.079

    • Vancouver

      Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 jun. 01 ] Available from: https://doi.org/10.33263/BRIAC131.079

  • Trabalho de evento-resumo periodico

    Effect of grinding procedures on the ritonavir-lopinavir system (2022)

    Pinheiro, L. B. M; Culbertson, Elizabeth; Araujo, Gabriel Lima Barros de ; Billinge, Simon; Ferreira, Fabio Furlan

    Source: Acta Crystallographica Section A. Conference titles: Congress and General Assembly of the International Union of Crystallography/IUCr. Unidade: FCF

    Subjects: FÁRMACOS, HIV

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PINHEIRO, L. B. M et al. Effect of grinding procedures on the ritonavir-lopinavir system. Acta Crystallographica Section A. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://scripts.iucr.org/cgi-bin/paper?S0108767321088164. Acesso em: 01 jun. 2024. , 2022

    • APA

      Pinheiro, L. B. M., Culbertson, E., Araujo, G. L. B. de, Billinge, S., & Ferreira, F. F. (2022). Effect of grinding procedures on the ritonavir-lopinavir system. Acta Crystallographica Section A. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://scripts.iucr.org/cgi-bin/paper?S0108767321088164

    • NLM

      Pinheiro LBM, Culbertson E, Araujo GLB de, Billinge S, Ferreira FF. Effect of grinding procedures on the ritonavir-lopinavir system [Internet]. Acta Crystallographica Section A. 2022 ; A77 C882 res. PS-19-6.[citado 2024 jun. 01 ] Available from: https://scripts.iucr.org/cgi-bin/paper?S0108767321088164

    • Vancouver

      Pinheiro LBM, Culbertson E, Araujo GLB de, Billinge S, Ferreira FF. Effect of grinding procedures on the ritonavir-lopinavir system [Internet]. Acta Crystallographica Section A. 2022 ; A77 C882 res. PS-19-6.[citado 2024 jun. 01 ] Available from: https://scripts.iucr.org/cgi-bin/paper?S0108767321088164

  • Artigo de periodico

    Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data (2022)

    Bezzon, Vinícius Danilo Nonato ; Pinto, Rogério da Silva; Araujo, Gabriel Lima Barros de ; Lima, João Cardoso de ; Ferreira, Fábio Furlan

    Source: Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: FÁRMACOS, MÉTODO DE MONTE CARLO, BIODISPONIBILIDADE

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BEZZON, Vinícius Danilo Nonato et al. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data. Journal of Pharmaceutical Sciences, v. 111, n. 11, p. 3054-3063, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2022.06.018. Acesso em: 01 jun. 2024.

    • APA

      Bezzon, V. D. N., Pinto, R. da S., Araujo, G. L. B. de, Lima, J. C. de, & Ferreira, F. F. (2022). Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data. Journal of Pharmaceutical Sciences, 111( 11), 3054-3063. doi:10.1016/j.xphs.2022.06.018

    • NLM

      Bezzon VDN, Pinto R da S, Araujo GLB de, Lima JC de, Ferreira FF. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data [Internet]. Journal of Pharmaceutical Sciences. 2022 ; 111( 11): 3054-3063.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.xphs.2022.06.018

    • Vancouver

      Bezzon VDN, Pinto R da S, Araujo GLB de, Lima JC de, Ferreira FF. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data [Internet]. Journal of Pharmaceutical Sciences. 2022 ; 111( 11): 3054-3063.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.xphs.2022.06.018

  • Artigo de periodico

    In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium (2022)

    Hajjar, Braa; Zuo, Jieyu; Park, Chulhun; Azarmi, Shirzad; Silva, Daniela Amaral; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: AAPS PharmSciTech. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HAJJAR, Braa et al. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, v. 23, p. 1-9 art. 102, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02258-0. Acesso em: 01 jun. 2024.

    • APA

      Hajjar, B., Zuo, J., Park, C., Azarmi, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, 23, 1-9 art. 102. doi:10.1208/s12249-022-02258-0

    • NLM

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1208/s12249-022-02258-0

    • Vancouver

      Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1208/s12249-022-02258-0

  • Artigo de periodico

    Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development (2022)

    Yousef, Malaz ; Park, Chulhun; Le, Tyson S; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar

    Source: Dissolutiom Technologies. Unidade: FCF

    Subjects: FÁRMACOS, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, v. 29, n. 2, p. 86-93, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P86. Acesso em: 01 jun. 2024.

    • APA

      Yousef, M., Park, C., Le, T. S., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, 29( 2), 86-93. doi:10.14227/DT290222P86

    • NLM

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 jun. 01 ] Available from: https://doi.org/10.14227/DT290222P86

    • Vancouver

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 jun. 01 ] Available from: https://doi.org/10.14227/DT290222P86

  • Artigo de jornal-dep/entr

    Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] (2022)

    Araujo, Gabriel Lima Barros de

    Source: Agência FAPESP. Unidade: FCF

    Subjects: FÁRMACOS, RADIAÇÃO SINCROTRON, DISPERSÃO DA LUZ

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ARAUJO, Gabriel Lima Barros de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler]. Agência FAPESP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP. Acesso em: 01 jun. 2024. , 2022

    • APA

      Araujo, G. L. B. de. (2022). Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler]. Agência FAPESP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.

    • NLM

      Araujo GLB de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] [Internet]. Agência FAPESP. 2022 ;08 fe 2022. on-line[citado 2024 jun. 01 ] Available from: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.

    • Vancouver

      Araujo GLB de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] [Internet]. Agência FAPESP. 2022 ;08 fe 2022. on-line[citado 2024 jun. 01 ] Available from: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.

  • Trabalho de evento-resumo

    Adverse drug events in an intensive care unit: a pilot study using the global trigger tool (2022)

    Souza, R. N. D; Moriel, Patricia ; Ventura, Deise de Souza; Perroud Junior, Mauricio Wesley ; Visacri, Marilia Berlofa

    Source: Abstracts. Conference titles: ISoP Annual Meeting "A New Era of Pharmacovigilance: Challenges and Opportunities". Unidade: FCF

    Subjects: FÁRMACOS, FARMACOVIGILÂNCIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOUZA, R. N. D et al. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. 2022, Anais.. London: International Society of Pharmacovigilance/ISOP, 2022. . Acesso em: 01 jun. 2024.

    • APA

      Souza, R. N. D., Moriel, P., Ventura, D. de S., Perroud Junior, M. W., & Visacri, M. B. (2022). Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. In Abstracts. London: International Society of Pharmacovigilance/ISOP.

    • NLM

      Souza RND, Moriel P, Ventura D de S, Perroud Junior MW, Visacri MB. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. Abstracts. 2022 ;[citado 2024 jun. 01 ]

    • Vancouver

      Souza RND, Moriel P, Ventura D de S, Perroud Junior MW, Visacri MB. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. Abstracts. 2022 ;[citado 2024 jun. 01 ]

  • Trabalho de evento

    In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons (2022)

    Yousef, Malaz ; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar

    Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF

    Subjects: FÁRMACOS, XENOBIÓTICO

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf. Acesso em: 01 jun. 2024.

    • APA

      Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf

    • NLM

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 jun. 01 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf

    • Vancouver

      Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 jun. 01 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf

  • Trabalho de evento

    In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium (2022)

    Hajjar, Braa; Zuo, Jieyu ; Azami, Shirzad; Silva, Daniela Amaral ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF

    Assunto: FÁRMACOS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HAJJAR, Braa et al. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf. Acesso em: 01 jun. 2024.

    • APA

      Hajjar, B., Zuo, J., Azami, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf

    • NLM

      Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 jun. 01 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf

    • Vancouver

      Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 jun. 01 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf

  • Artigo de periodico

    Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations (2022)

    Prieto, Diego Campos ; Araujo, Renan Vinicius de ; Lima, Sara de Souza; Assad, Felipe Zauith; Grayson, Scott M; Braga, Ataualpa Albert Carmo ; Lourenço, Felipe Rebello ; Giarolla, Jeanine

    Source: Journal of Molecular Structure. Unidades: IQ, FCF

    Subjects: TUBERCULOSE, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PRIETO, Diego Campos et al. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, v. 1254, p. 1-7 art. 132323, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.molstruc.2021.132323. Acesso em: 01 jun. 2024.

    • APA

      Prieto, D. C., Araujo, R. V. de, Lima, S. de S., Assad, F. Z., Grayson, S. M., Braga, A. A. C., et al. (2022). Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations. Journal of Molecular Structure, 1254, 1-7 art. 132323. doi:10.1016/j.molstruc.2021.132323

    • NLM

      Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323

    • Vancouver

      Prieto DC, Araujo RV de, Lima S de S, Assad FZ, Grayson SM, Braga AAC, Lourenço FR, Giarolla J. Succinylated isoniazid potential prodrug: design of Experiments (DoE) for synthesis optimization and computational study of the reaction mechanism by DFT calculations [Internet]. Journal of Molecular Structure. 2022 ; 1254 1-7 art. 132323.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.molstruc.2021.132323

  • Artigo de periodico

    Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test (2022)

    Chauca, Enma Perez ; Plasencia, Pedro M. Alva ; Ferraz, Humberto Gomes

    Source: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF

    Subjects: ESPECTROFOTOMETRIA, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CHAUCA, Enma Perez e PLASENCIA, Pedro M. Alva e FERRAZ, Humberto Gomes. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, v. 10, n. 5, p. 847-856, 2022Tradução . . Disponível em: https://doi.org/10.56499/jppres22.1433_10.5.847. Acesso em: 01 jun. 2024.

    • APA

      Chauca, E. P., Plasencia, P. M. A., & Ferraz, H. G. (2022). Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, 10( 5), 847-856. doi:10.56499/jppres22.1433_10.5.847

    • NLM

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jun. 01 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847

    • Vancouver

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jun. 01 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847

  • Artigo de periodico

    Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review (2022)

    Reyes, Pia Loren ; Saavedra, Nicolás ; Torso, Nadine de Godoy ; Visacri, Marilia Berlofa ; Moriel, Patricia ; Salazar, Luis Antônio

    Source: Frontiers in Pharmacology. Unidade: FCF

    Subjects: FÁRMACOS, MICRORNAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      REYES, Pia Loren et al. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, v. 13, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.831099. Acesso em: 01 jun. 2024.

    • APA

      Reyes, P. L., Saavedra, N., Torso, N. de G., Visacri, M. B., Moriel, P., & Salazar, L. A. (2022). Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, 13, 1-19. doi:10.3389/fphar.2022.831099

    • NLM

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fphar.2022.831099

    • Vancouver

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fphar.2022.831099

  • Artigo de periodico

    Insights into newly approved drugs from a medicinal chemistry perspective (2021)

    Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart

    Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF

    Assunto: FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 01 jun. 2024.

    • APA

      Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328

    • NLM

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2174/1389557521666210226145328

    • Vancouver

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2174/1389557521666210226145328

  • Apresentacao sonora/cenica/entrevista

    Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança (2021)

    Trossini, Gustavo Henrique Goulart ; Lopes, Norberto Peporine

    Source: Jornal da USP. Unidades: FCF, FCFRP

    Subjects: FÁRMACOS, COVID-19

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TROSSINI, Gustavo Henrique Goulart e LOPES, Norberto Peporine. Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança. Jornal da USP. São Paulo: Universidade de São Paulo - USP. Disponível em: https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca. Acesso em: 01 jun. 2024. , 2021

    • APA

      Trossini, G. H. G., & Lopes, N. P. (2021). Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança. Jornal da USP. São Paulo: Universidade de São Paulo - USP. Recuperado de https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca

    • NLM

      Trossini GHG, Lopes NP. Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança [Internet]. Jornal da USP. 2021 ;[citado 2024 jun. 01 ] Available from: https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca

    • Vancouver

      Trossini GHG, Lopes NP. Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança [Internet]. Jornal da USP. 2021 ;[citado 2024 jun. 01 ] Available from: https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca

1 - 20 (342 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024